thiophenes has been researched along with abt-737 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ba, Q; Chen, S; Li, J; Li, Y; Liu, Z; Ma, D; Wang, H; Wang, R; Yan, X; Yang, C; Zhang, Z; Zhou, M | 1 |
| Bigner, DD; Chandramohan, V; Dobrikov, M; Gromeier, M; Keir, ST; Pastan, IH; Reisfeld, R; Yu, X | 1 |
2 other study(ies) available for thiophenes and abt-737
| Article | Year |
|---|---|
Development of 3-phenyl-N-(2-(3-phenylureido)ethyl)-thiophene-2-sulfonamide compounds as inhibitors of antiapoptotic Bcl-2 family proteins.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Biphenyl Compounds; Caspase 9; Cell Line, Tumor; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Molecular Docking Simulation; Nitrophenols; Piperazines; Poly(ADP-ribose) Polymerases; Protein Interaction Domains and Motifs; Protein Structure, Tertiary; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Sulfonamides; Thiophenes | 2014 |
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzothiazoles; Biphenyl Compounds; Brain Neoplasms; Cell Death; Cell Line, Tumor; Chondroitin Sulfate Proteoglycans; Drug Synergism; Endocytosis; Exotoxins; Furin; Humans; Immunotoxins; Isoquinolines; Membrane Proteins; Mice, Nude; Models, Biological; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Signal Transduction; Sulfonamides; Survival Analysis; Thiophenes; Time Factors; Xenograft Model Antitumor Assays | 2019 |